CIK 0001759425 · Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831281555
- Phone
- 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,138,950
- in 6 filings, $4.8M under 10b5-1 plans
Net −$11,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | GREY MICHAEL G Director | Grant or award · Restricted Stock Units | +1,980 | 1,980 | ||
| 2026-06-09 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +2,393 | $26.49 | $63K | 47,181 |
| 2026-06-09 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −2,393 | 26,653 | ||
| 2026-06-08 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,258 | $92.84 | $210K | 47,530 |
| 2026-06-08 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,175 | $93.95 | $110K | 46,355 |
| 2026-06-08 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,567 | $95.12 | $149K | 44,788 |
| 2026-06-05 | Radovich Peter PRESIDENT AND COO | Option exercise | +16,988 | $19.19 | $326K | 57,260 |
| 2026-06-05 | Radovich Peter PRESIDENT AND COO | Option exercise · Stock Option (right to buy) | −16,988 | 48,012 | ||
| 2026-06-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +30,000 | $2.94 | $88K | 224,309 |
| 2026-06-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,602 | $94.64 | $246K | 221,707 |
| 2026-06-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −16,595 | $95.34 | $1.6M | 205,112 |
| 2026-06-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,926 | $96.15 | $666K | 198,186 |
| 2026-06-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,973 | $97.56 | $192K | 196,213 |
| 2026-06-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,021 | $98.20 | $100K | 195,192 |
| 2026-06-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −883 | $99.66 | $88K | 194,309 |
| 2026-06-01 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −30,000 | 128,487 | ||
| 2026-06-01 | Ramasastry Saira Director | Sale | −3,977 | $100.00 | $398K | 0 |
| 2026-05-29 | Cardon Lon Director | Option exercise | +3,977 | 9,680 | ||
| 2026-05-29 | Cardon Lon Director | Option exercise · Restricted Stock Units | −3,977 | 0 | ||
| 2026-05-29 | Ramasastry Saira Director | Option exercise | +3,977 | 3,977 |
Page 4 of 15 · 294 trades